Long-term clinical and echocardiographic outcomes after mitral valve surgery for severe mitral annular calcification
- 1Medical Faculty, RWTH Aachen University
- 2Department of Endovascular Surgery, University Clinic of Brandenburg/Havel
- 3Department of Cardiothoracic Surgery, Helios Hospital Siegburg
Abstract
Objective: To assess the long-term clinical and echocardiographic outcomes of mitral valve surgery with annular decalcification and pericardial patch reconstruction in patients with severe mitral annular calcification (MAC).
Patients and methods: Between 2012 and 2022, 112 consecutive high-risk patients (67 women, 45 men; mean age 66.5 ± 13.6 years) underwent surgery for severe MAC with mitral stenosis and/or regurgitation. Mitral valve repair was performed in 55 patients (49%) and replacement in 57 (51%). Concomitant procedures were performed in 65 patients (58%). Mean follow-up was 97 ± 48 months.
Results: Early mortality was 6.3% ( n = 7) and late mortality was 23.2% ( n = 26). Survival was 89.3%, 77.2%, and 64.1% at 60, 96, and 144 months, respectively. Freedom from reoperation was 98.3% at 60 months and 93.3% at 96 months. At follow-up, no surviving patient had more than grade III mitral regurgitation. Grade III regurgitation was present in 3 patients (4%), while no patient had grade IV regurgitation. Left atrial diameter, left ventricular end-diastolic diameter, and mean transvalvular gradient were significantly lower than before surgery.
Conclusion: In this high-risk cohort, annular decalcification and pericardial patch reconstruction provided durable valve function and acceptable long-term survival in patients who survived the perioperative period. Perioperative mortality, however, remained substantial.
Related
- Posterior neo-annular reconstruction: An alternative approach to mitral valve replacement for caseous mitral annular calcification
- An unexpected embolic source: mitral annular calcification presenting with stroke and myocardial infarction—case report
- Mitral Transcatheter Edge-to-Edge Repair in a Challenging Anatomy With Deeply Implanted Self-Expanding Valve and Severe Mitral Annular Calcification: A Case Report
- Histopathological insights into a swinging cardiac calcified amorphous tumor associated with mitral annular calcification: A case report
- Clinical outcomes and recovery impact of implementing enhanced recovery after surgery (ERAS) pathway in elderly patients with gynecological malignant tumors
BibTeX
@article{dharuman2026longterm,
title = {{Long-term clinical and echocardiographic outcomes after mitral valve surgery for severe mitral annular calcification}},
author = {Yoganiranjana Dharuman and Egan Kalmykov and Mirko Doss},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
month = oct,
doi = {10.3389/fcvm.2026.1881651},
url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1881651/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Long-term clinical and echocardiographic outcomes after mitral valve surgery for severe mitral annular calcification
AU - Yoganiranjana Dharuman
AU - Egan Kalmykov
AU - Mirko Doss
PY - 2026
DA - 2026/10/28
JO - Frontiers in Cardiovascular Medicine
DO - 10.3389/fcvm.2026.1881651
UR - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1881651/full
AB - Objective: To assess the long-term clinical and echocardiographic outcomes of mitral valve surgery with annular decalcification and pericardial patch reconstruction in patients with severe mitral annular calcification (MAC). Patients and methods: Between 2012 and 2022, 112 consecutive high-risk patients (67 women, 45 men; mean age 66.5 ± 13.6 years) underwent surgery for severe MAC with mitral stenosis and/or regurgitation. Mitral valve repair was performed in 55 patients (49%) and replacement in 57 (51%). Concomitant procedures were performed in 65 patients (58%). Mean follow-up was 97 ± 48 months. Results: Early mortality was 6.3% ( n = 7) and late mortality was 23.2% ( n = 26). Survival was 89.3%, 77.2%, and 64.1% at 60, 96, and 144 months, respectively. Freedom from reoperation was 98.3% at 60 months and 93.3% at 96 months. At follow-up, no surviving patient had more than grade III mitral regurgitation. Grade III regurgitation was present in 3 patients (4%), while no patient had grade IV regurgitation. Left atrial diameter, left ventricular end-diastolic diameter, and mean transvalvular gradient were significantly lower than before surgery. Conclusion: In this high-risk cohort, annular decalcification and pericardial patch reconstruction provided durable valve function and acceptable long-term survival in patients who survived the perioperative period. Perioperative mortality, however, remained substantial.
SN - 2297-055X
ER -